Evidence map›Paper›PMID 36563140›Full record

ArticleScience advances2022

Regulation of eIF4E guides a unique translational program to control erythroid maturation.

Craig M Forester, Juan A Oses-Prieto, Nancy J Phillips, Sohit Miglani, Xiaming Pang, Gun Woo Byeon, Rachel DeMarco, Al Burlingame, Maria Barna, Davide Ruggero

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Effects ofCurrent issues in molecular biology · 2024
    Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Craig M ForesterDepartment of Pediatrics, University of Colorado, Denver, CO 80045, USA.ORCID 0000-0002-1868-5760
Juan A Oses-PrietoDepartment of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158, USA.ORCID 0000-0003-4759-2341
Nancy J PhillipsDepartment of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158, USA.
Sohit MiglaniDepartment of Urology, University of California, San Francisco, San Francisco, CA, USA.ORCID 0000-0002-8075-320X
Xiaming PangDepartment of Urology, University of California, San Francisco, San Francisco, CA, USA.
Gun Woo ByeonDepartment of Genetics, Stanford University School of Medicine, Stanford, CA 94309, USA.ORCID 0000-0001-5022-4342
Rachel DeMarcoDepartment of Pediatrics, University of Colorado, Denver, CO 80045, USA.
Al BurlingameDepartment of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158, USA.ORCID 0000-0002-8403-7307
Maria BarnaDepartment of Genetics, Stanford University School of Medicine, Stanford, CA 94309, USA.ORCID 0000-0002-6843-4396
Davide RuggeroDepartment of Urology, University of California, San Francisco, San Francisco, CA, USA.ORCID 0000-0002-9444-5865
University of California, San Francisco · USStanford University · USUniversity of Colorado Denver · US

Funding

Mechanisms of regulated translation control in cancer and its therapeutic implicationsR35CA242986 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI RUGGERO, DAVIDE · 2019 to 2025
$6.4M
Research Training in Childhood CancerT32CA128583 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Eric Alejandro Sweet-Cordero · 2007 to 2026
$6.0M
Profiling Translational Control of Gene Expression and Nascent Proteomic Responses in Erythropoietic Progression and RibosomopathiesK08DK119561 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI FORESTER, CRAIG M. · 2019 to 2022
$781k
NCI NIH HHS R35 CA242986NCI NIH HHS T32 CA128583NIDDK NIH HHS K08 DK119561
6 · The paper itself

Abstract

Translation control is essential in balancing hematopoietic precursors and differentiation; however, the mechanisms underlying this program are poorly understood. We found that the activity of the major cap-binding protein eIF4E is unexpectedly regulated in a dynamic manner throughout erythropoiesis that is uncoupled from global protein synthesis rates. Moreover, eIF4E activity directs erythroid maturation, and increased eIF4E expression maintains cells in an early erythroid state associated with a translation program driving the expression of PTPN6 and Igf2bp1. A cytosine-enriched motif in the 5' untranslated region is important for eIF4E-mediated translation specificity. Therefore, selective translation of key target genes necessary for the maintenance of early erythroid states by eIF4E highlights a unique mechanism used by hematopoietic precursors to rapidly elicit erythropoietic maturation upon need.

Identifiers

PMID36563140
PMCPMC9788769
OpenAlexW4312179009

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.